Increased STAT1 signaling in endocrine-resistant breast cancer.
Proteomic profiling of the estrogen/tamoxifen-sensitive MCF-7 cell line and its partially sensitive (MCF-7/LCC1) and fully resistant (MCF-7/LCC9) variants was performed to identify modifiers of endocrine sensitivity in breast cancer. Analysis of the expression of 120 paired phosphorylated and non-ph...
Main Authors: | Rui Huang, Dana Faratian, Andrew H Sims, Danielle Wilson, Jeremy S Thomas, David J Harrison, Simon P Langdon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3984130?pdf=render |
Similar Items
-
Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy.
by: Dana Faratian, et al.
Published: (2011-01-01) -
GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines
by: Morgan Kevin, et al.
Published: (2011-11-01) -
Endocrine Resistance and Notch Signalling Pathway in Breast Cancer
by: Andreia Marisa Ribeiro da Silva
Published: (2019) -
Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
by: Jing-Wen Bai, et al.
Published: (2020-06-01) -
A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
by: Ahmet Acar, et al.
Published: (2016-01-01)